Gene Query: SSNA1

Dataset Description Geneva Score
Energy Metabolism during Anchorage-Independence 22.28
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 20.47
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 20.4
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 20.4
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 18.57
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 17.57
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 16.05
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 15.71
Regulation of highly expressed hCINAP on translatome 14.86
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 14.72
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 14.4
Differential gene expression of human melanoma cells [RNA-seq] 14.4
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 13.88
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 13.88
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 13.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.28
The comparison of high-throughput single-cell RNA-seq methods 13.13
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 11.79
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.76
Comprehensive comparative analysis of 5’ end RNA sequencing methods 11.56
hTERT promotes cell adhesion and migration independent of telomerase activity 11.4
Global analysis of enhancer targets: Mosaic-seq 10.99
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.77
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.27
Biological effect of chronic mistranslation in mammalian cells 10.2
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 10.13
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.93
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 9.81
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 9.81
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 9.77
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 9.6
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 9.5
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 9.48
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 9.42
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 9.35
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.31
CROP-Seq in Primary Human T Cells 9.24
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.07
Impact of dieldrin on transcription in Jurkat T cells 8.99
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 8.78
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 8.78
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 8.7
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 8.7
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.7
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 8.48
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 8.44
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.41
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 8.34
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 8.19
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 8.13
Comparing gene expression in iPSC derived RPE from control and AMD donors 8.13
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.09
METTL3 promotes translation in human cancer cells 8.04
scRNASeq analysis of cycling cardiomyocytes 8.02
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 8.01
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 8.0
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 7.91
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 7.88
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 7.83
Ebola virus (EBOV) infection of ARPE-19 cells 7.81
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 7.71
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.67
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 7.65
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.65
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.6
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.55
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.45
Survival of pancreatic cancer cells lacking KRAS function 7.3
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 7.27
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 7.27
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 7.27
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.26
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.25
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.25
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 7.23
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 7.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 7.18
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 7.14
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 7.14
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.13
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.13
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.13
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 7.1
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 7.07
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.95
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 6.76
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 6.75
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.71
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 6.7
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 6.65
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.64
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.61
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.51
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 6.5
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 6.5
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 6.48
PRDM1 inhibits proliferation of human colon cancer organoids 6.48
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 6.47
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.43
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.43
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.42
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.4
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 6.33
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 6.31
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.3
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.27
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.25
Glioblastoma stem cells infected by ZIKA virus 6.24
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 6.19
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.15
High-throughput sequencing of pluripotent cells 6.1
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.08
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.07
KLF6-dependent transcription in renal cancer cells 6.07
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 6.02
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.02
Global Mapping of Human RNA-RNA Interactions 5.99
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.95
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.91
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 5.91
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.87
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 5.84
Transcriptome analysis of SKI knock-out in HL60 cells 5.84
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.83
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.83
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.82
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.79
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.79
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 5.71
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 5.71
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 5.71
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 5.67
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 5.67
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.66
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.66
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 5.65
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 5.62
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.6
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 5.57
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.55
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.55
CD95/Fas ligand mRNA is toxic to cells 5.52
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.52
PTHrP overexpression in MCF7 cells 5.5
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.5
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.49
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.46
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.43
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.43
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 5.41
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 5.39
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 5.39
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 5.39
Effect of FGF13 depletion on the H460 cell line 5.36
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 5.33
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.33
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.32
Total RNA sequencing of WT intestinal orgaonids. 5.31
Differetially expressed genes after hTR overexpression in U2OS cells 5.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.25
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.23
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 5.23
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 5.22
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.22
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.22
G-quadruplex structures mark human regulatory chromatin 5.2
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.18
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.16
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.15
Stem and effector CD8 T-cells from human cancers 5.15
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 5.14
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 5.12
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.11
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 5.07
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 5.07
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 5.06
SETBP1-WT and SETBP1-G870S epigenetic landscapes 5.06
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 5.02
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.01
Regulation of poly(A) tail and translation during the somatic cell cycle 4.98
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.96
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.92
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.91
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 4.9
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.9
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.89
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.85
U1 snRNP telescripting regulates size-function stratified human genome 4.83
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 4.77
DAOY-Notch1/Notch2 knockout: transcriptome comparison 4.76
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.73
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 4.71
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.67
High-Throughput Kinetic Analysis of Fractional Killing 4.65
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.63
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.63
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.6
RNA-seq analysis of control and Myc-induced U2OS cells 4.55
RNAseq of cell lines with knocked in ESR1 mutations 4.54
The transcriptome effect of overexpressing EZH2 in MCF7 4.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.5
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 4.49
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.48
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.48
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 4.44
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.41
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.41
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.39
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.38
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.35
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.33
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.3
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 4.29
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.27
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 4.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 4.27
RNA-seq analysis upon ARID1B overexpression 4.27
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.25
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 4.24
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 4.21
Conservative alteration of chromosomal expression pattern across human solid tumor types 4.2
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.2
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.2
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.19
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 4.18
Human Treg NaCl stimulation 4.16
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.13
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.11
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 4.1
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.09
LNCaP treated with iBET 4.06
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.05
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.01
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.98
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.96
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.94
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.92
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.89
Co-regulation of splicing by Rbfox1 and hnRNP M 3.86
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.86
Endothelial gene expression analysis 3.85
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.85
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 3.85
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.83
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.78
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 3.75
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 3.75
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.75
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.74
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 3.71
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 3.71
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.7
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 3.69
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 3.65
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.62
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 3.6
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.6
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.6
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.56
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.55
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.53
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.52
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.52
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.51
Expression data from miR340 overexpressing human A549 cells 3.51
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.51
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.5
RNA editing in nascent RNA affects pre-mRNA splicing 3.49
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.46
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.43
RNA-seq of RKO cells with cTAZ KO or putback 3.42
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.4
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.4
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.37
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.37
Active translatome profiling with RiboLace in MCF7 cells 3.36
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.33
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.31
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.3
Functional role of CPPED1 in trophoblasts. 3.27
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.26
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.25
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 3.22
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.21
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.21
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.2
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.15
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.15
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.12
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.12
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.1
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.08
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.08
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.08
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.07
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.07
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.03
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.98
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.93
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.85
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.85
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.83
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.83
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.82
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.77
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.73
Gene expression profiling of leukemia cells following asparagine depletion 2.72
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.69
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.57
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.57
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 2.52
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.52
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.49
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 2.49
Human Treg IL-12 stimulation 2.49
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.47
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.46
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.4
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.4
Tracking distinct RNA populations using efficient and reversible covalent chemistry 2.37
Cajal bodies are linked to genome conformation 2.35
Cajal bodies are linked to genome conformation [RNA-Seq] 2.35
Gene expression analysis upon mtDNA depletion 2.35
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.35
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.33
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.31
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.31
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.3
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.29
Transcriptome sequencing of K-562 cells 2.28
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.27
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.23
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.22
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.22
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.17
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.17
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.16
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.16
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.15
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.15
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.13
Ribosome profiling upon inhibition of eIF4A 2.1
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.09
RNA-Seq of PRMT1 overexpression ECA109 cells 2.04
Identification of long noncoding RNAs regulated by p53 2.03
RNA-sequencing of healthy human skeletal myocytes 2.03
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.0
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.0
Functional significance of the HIV-1 Tat signature amino acid residues 1.94
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.86
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.83
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.82
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.81
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.74
The cohesin complex prevents Myc-induced replication stress 1.74
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.74
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.71
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.71
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.69
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.69
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 1.68
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.66
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.64
Positively selected enhancer elements endow tumor cells with metastatic competence 1.62
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.61
Oncogenic roles of ARID5B in T-ALL 1.6
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.6
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.54
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.54
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.51
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.51
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 1.51
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 1.51
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 1.5
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 1.49
Effect of ILF3 on translation during homeostasis and the antiviral response 1.49
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.46
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.44
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.44
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.43
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.42
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.37
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.37
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.37
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.36
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.36
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.35
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.33
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.32
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.32
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.29
Copper Regulation of HIF-1 Transcription Activity 1.29
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.27
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.26
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.19
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.17
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.17
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.14
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.14
SRSF1 role in cellular gene expression and splicing 1.12
Exploring ILF2 regulatory genes by next-generation sequencing 1.1
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.1
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.09
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.05
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.04
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.03
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.01
The bromodomain protein BRD4 regulates splicing during heat shock 0.98
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 0.94
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.88
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.87
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.86
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.82
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.82
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.82
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.81
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.81
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 0.78
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.76
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.75
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.74
miRNAs affected by antagomiR-17 treatment 0.74
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.73
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.73
H1609088 Human RNA-Sequencing 0.72
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.71
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.67
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.67
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.63
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.63
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.62
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.59
Expression profiling of MCF-7 cells with treatment of TCDD 0.59
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.58
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.57
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.57
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.57
m6A-dependent regulation of messenger RNA stability 0.57
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.53
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.53
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.52
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.52
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.49
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.47
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.45
RNA-seq differential expression studies: more sequence, or more replication? 0.45
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.43
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.41
The DPYSL2 gene connects mTOR and schizophrenia 0.37
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.35
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.35
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.34
The circadian transcriptional landscape in primary human mammary epithelial cells 0.34
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.33
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.32
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.31
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.3
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.3
FBXW7 modulates stress response by post-translational modification of HSF1 0.28
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.28
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.25
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.25
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.2
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.2
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.19
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.19
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.19
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.19
Enhancer activation during EGF response 0.18
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.17
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.17
Irf9 function in immunity in mouse 0.16
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 0.16
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.16
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.15
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
RNA-seq data from human lymphoma cell lines 0.14
ChIP-seq and RNA-seq from human lymphoma cell lines 0.14
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.14
Myc activation coordinates gene transcription and protein translation responses 0.14
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.13
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.13
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.1
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.1
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.09
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.05
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.03
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.02
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.01
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation